drugset / Trial / NCT07174115
A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this clinical trial is to assess the efficacy and safety of HTMC0658 tablets in treating subjects with chronic rhinosinusitis without nasal polyps (CRSsNP).
Timeline
- Start
- 2025-08-18
- Primary completion
- 2026-04
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HTMC0658 | Unknown | — | Oral |